Benutzt von | als | Name | Version |
---|
2.16.840.1.113883.3.1937.99.61.26.4.7 | Transaktion | Base Document | 2016‑10‑08 19:37:05 |
2.16.840.1.113883.2.9.10.1.10.4.3 | Transaktion | (it-IT) Crea Act | 2018‑07‑20 17:01:17 |
2.16.840.1.113883.3.1937.99.61.5.4.22 | Transaktion | CDA Document APSR2 | 2014‑11‑16 11:45:10 |
2.16.840.1.113883.2.9.77.2.4.3 | Transaktion | Triage | 2017‑03‑02 11:11:11 |
2.16.840.1.113883.3.1937.777.15.4.8 | Transaktion | Create Medication Dispense | 2019‑02‑17 |
2.16.756.5.30.1.127.77.2.4.4 | Transaktion | CDA-CH - StructuredBody Enhanced (2018) | 2018‑02‑12 17:54:58 |
2.16.840.1.113883.3.1937.777.22.4.20 | Transaktion | CDA MiBi | 2018‑08‑31 08:54:30 |
1.2.208.184.4.2 | Transaktion | Initial | 2018‑11‑19 22:06:20 |
2.16.840.1.113883.2.6.60.6.4.2 | Transaktion | CDA Dokument Strukturierter Pathologiebefund (2.0) | 2015‑10‑23 10:32:36 |
2.16.840.1.113883.2.9.77.2.4.5 | Transaktion | (it-IT) Dimissioni | 2017‑09‑28 12:23:20 |
2.16.840.1.113883.3.1937.777.60.4.5 | Transaktion | Rune (01) | 2023‑07‑04 14:19:29 |
2.16.756.5.30.1.127.77.6.4.2 | Transaktion | Laboratory Report within a transplantation process | 2016‑05‑01 |
2.16.840.1.113883.3.1937.99.61.32.4.4 | Transaktion | Initial | 2017‑06‑21 15:05:59 |
2.16.840.1.113883.3.1937.777.20.4.2 | Transaktion | Genetic Testing Report (GTR) (DSTU Release 1) | 2018‑03‑22 11:37:04 |
1.2.208.184.4.8 | Transaktion | Initial | 2019‑12‑07 23:24:59 |
2.16.840.1.113883.3.1937.777.15.4.4 | Transaktion | Create Medication Statement | 2017‑05‑10 |
2.16.840.1.113883.2.9.10.1.10.4.4 | Transaktion | (it-IT) Crea Sezione | 2018‑07‑20 17:02:38 |
2.16.840.1.113883.3.1937.777.15.4.6 | Transaktion | Create Medication Administration | 2019‑02‑17 |
2.16.840.1.113883.3.1937.777.15.4.2 | Transaktion | Create Medication Order | 2017‑05‑10 |
2.16.756.5.30.1.127.77.2.4.2 | Transaktion | CDA-CH - StructuredBody (2020) | 2017‑11‑10 09:35:28 |
2.16.840.1.113883.3.1937.99.61.38.4.2 | Transaktion | F2102 Entlassungsbericht | 2017‑11‑08 10:42:23 |
1.2.40.0.34.6.0.11.3.139 | | EXNDS Preis Arzneimittel (1.0.0+20210310) | 2020‑10‑06 15:47:15 |
1.2.40.0.34.11.13.3.20 | | Informant (Body) PS | 2017‑08‑10 20:44:29 |
1.2.208.184.2.10.9 | | CDA ClinicalDocument (with StructuredBody) | 2023‑07‑04 08:28:40 |
1.2.208.184.10.1.10 | | DK ClinicalDocument (with StructuredBody) | 2021‑08‑30 14:09:05 |
1.2.208.184.10.1.13 | | DK Medcom ClinicalDocument (with StructuredBody) (1.5) | 2021‑08‑30 14:26:22 |
1.2.208.184.10.1.17 | | DK Medcom DocumentationOf (1.5) | 2021‑08‑31 13:19:19 |
1.2.208.184.10.1.43 | | DK Resume Document Template (1.1) | 2023‑07‑04 13:08:22 |
1.2.208.184.10.1.44 | | DK Medcom ClinicalDocument (with StructuredBody) (1.5) | 2023‑07‑04 13:52:36 |
1.2.208.184.10.1.45 | | DK CDA Header (2.0) | 2023‑07‑04 13:57:28 |
1.2.208.184.10.1.46 | | DK Personal Data Card (3.0) | 2023‑08‑08 10:15:04 |
1.2.208.184.10.2 | | Care plan Document | 2018‑11‑19 21:13:46 |
1.2.208.184.10.3 | | Personal Data Card Document | 2019‑11‑12 23:27:01 |
1.2.208.184.10.9 | Containment | PDC DK CDA author | 2019‑12‑14 16:27:36 |
1.2.208.184.10.13 | | PDC DK CDA documentationOf | 2019‑12‑14 17:03:50 |
1.2.208.184.10.14 | | PDC DK CDA documentationOf | 2019‑12‑14 17:04:01 |
1.2.208.184.10.15 | | PDC DK CDA Section | 2019‑12‑14 17:24:10 |
1.2.208.184.10.32 | | APD CDA Clinical Statement | 2020‑06‑21 16:54:06 |
1.2.208.184.10.33 | | APD CDA Observation | 2020‑06‑21 17:05:15 |
1.2.208.184.11.1.1 | | DK CDA ClinicalDocument (with StructuredBody) | 2021‑08‑13 10:06:00 |
1.2.208.184.14.11.2 | | Appointment CDA Encounter | 2019‑12‑15 23:32:24 |
1.2.208.184.15.1.10.20.1 | | Health Concern Section | 2018‑11‑28 20:54:17 |
1.2.208.184.15.1.10.20.1.2 | | Health Concern Sub Section | 2018‑11‑19 22:02:34 |
1.2.208.184.15.1.10.20.2 | | Goal Section | 2018‑11‑28 20:58:20 |
1.2.208.184.15.1.10.20.2.2 | | Goal Sub Section | 2018‑11‑19 22:19:45 |
1.2.208.184.15.1.10.20.3 | | Interventions Section | 2018‑11‑28 21:00:20 |
1.2.208.184.15.1.10.20.3.2 | | Interventions Sub Section | 2018‑11‑19 22:22:11 |
1.2.208.184.15.1.10.20.4 | | Outcomes Section | 2018‑11‑28 21:01:23 |
1.2.208.184.15.1.10.20.4.2 | | Outcomes Sub Section | 2018‑11‑19 22:33:18 |
1.2.208.184.16.1.10.20.1.20 | | PDC DK Language CDA Observation | 2019‑12‑22 11:41:45 |
1.2.208.184.16.1.10.20.1.21 | | PDC DK Temporary Address CDA Observation | 2019‑12‑22 11:43:31 |
1.2.208.184.16.1.10.20.1.22 | | PDC DK Dentist CDA Observation | 2019‑12‑22 11:45:33 |
1.2.208.184.16.1.10.20.1.23 | | PDC DK Custody CDA Observation | 2019‑12‑22 11:22:08 |
1.2.208.184.16.1.10.20.1.24 | | PDC DK Contact CDA Observation | 2019‑12‑22 11:46:44 |
1.2.208.184.16.1.10.20.1.25 | | PDC DK Relative CDA Observation | 2019‑12‑22 11:48:03 |
1.2.208.184.16.1.10.20.1.26 | | PDC DK Citizen CDA Observation | 2019‑12‑22 11:29:00 |
1.2.208.184.16.1.10.20.1.27 | | PDC DK Coverage CDA Observation | 2019‑12‑22 11:33:55 |
1.2.208.184.16.1.10.20.1.28 | | PDC DK Organ CDA Observation | 2019‑12‑22 11:35:31 |
1.2.208.184.16.1.10.20.1.29 | | PDC DK Treatment Will CDA Observation | 2019‑12‑22 11:38:15 |
1.2.208.184.16.1.10.20.1.30 | | PDC DK Living Will CDA Observation | 2019‑12‑22 11:39:56 |
1.2.276.0.76.3.1.81.81.12.1.10.5 | Containment | CDA participant (efacons) | 2015‑03‑30 19:06:20 |
1.2.276.0.76.3.1.85.200.77.10.2 | | Diagnose | 2016‑01‑29 12:27:26 |
1.2.276.0.76.3.1.85.200.77.10.3 | | Therapie | 2016‑01‑29 12:28:19 |
1.2.276.0.76.3.1.85.200.77.10.4 | | Wundbeurteilung | 2016‑01‑29 12:33:12 |
1.2.276.0.76.3.1.85.200.77.10.5 | | Wundbericht | 2016‑01‑29 12:40:29 |
1.2.276.0.76.3.1.85.200.77.10.7 | | psychosoziale Faktoren | 2016‑02‑04 15:14:55 |
1.2.276.0.76.3.1.85.200.77.10.8 | | individuelle Risikofaktoren | 2016‑02‑04 15:24:45 |
1.2.276.0.76.3.1.85.200.77.10.9 | | Risikoasssessment | 2016‑02‑04 15:28:02 |
1.2.276.0.76.3.1.85.200.77.10.10 | | HygieneAssessment | 2016‑02‑04 15:30:47 |
1.2.276.0.76.3.1.85.200.77.10.11 | | Hautassessment | 2016‑02‑04 15:33:52 |
1.2.276.0.76.3.1.85.200.77.10.12 | | Details über geheilte Wunden | 2016‑02‑04 15:37:09 |
1.2.276.0.76.3.1.85.200.77.10.13 | | gesundheitsrelevantes Patientenverhalten | 2016‑02‑04 15:45:40 |
1.2.276.0.76.3.1.85.200.77.10.14 | | körperliche Beeinträchtigungen | 2016‑02‑04 15:48:19 |
1.2.276.0.76.3.1.85.200.77.10.15 | | psychosoziale Beeinträchtigungen | 2016‑02‑04 15:51:13 |
1.2.276.0.76.3.1.85.200.77.10.17 | | relevante med. Daten | 2016‑02‑04 16:07:34 |
1.2.276.0.76.3.1.85.200.77.10.18 | | Behandlungsziele | 2016‑02‑04 16:17:24 |
1.2.276.0.76.3.1.85.200.77.10.19 | | Behandlungsplan | 2016‑02‑04 16:22:01 |
1.2.276.0.76.3.1.85.200.77.10.20 | | benötigte Ausrüstung | 2016‑02‑04 16:27:22 |
1.2.276.0.76.3.1.85.200.77.10.21 | | Heilungs- und Therapieverlauf | 2016‑02‑04 16:32:28 |
1.2.276.0.76.3.1.85.200.77.10.22 | | Schmerzmanagement | 2016‑02‑04 16:36:00 |
1.2.276.0.76.3.1.85.200.77.10.23 | | Hygienemaßnahmen | 2016‑02‑04 16:40:10 |
1.2.276.0.76.3.1.85.200.77.10.24 | | Wundrandschutz | 2016‑02‑04 16:43:46 |
1.2.276.0.76.3.1.85.200.77.10.25 | | Kausaltherapie | 2016‑02‑04 16:46:11 |
1.2.276.0.76.3.1.85.200.77.10.26 | | Patientenedukation | 2016‑02‑04 16:49:29 |
1.2.276.0.76.3.1.85.200.77.10.27 | | bisherige Ergebnisse | 2016‑02‑04 16:54:50 |
1.2.276.0.76.3.1.85.200.77.10.29 | | Photo | 2016‑03‑02 11:05:48 |
1.2.276.0.76.3.1.85.200.77.10.40 | | Vitaldatenbeurteilung | 2016‑04‑07 13:38:34 |
1.2.276.0.76.3.1.85.200.77.10.43 | | Entlassbericht | 2016‑09‑27 18:04:29 |
1.3.6.1.4.1.19376.1.3.1.6 | | IHE Laboratory Observation (LAB TF-3, Revision 6.0 - Final Text, July 14, 2015) | 2016‑06‑24 13:58:31 |
1.3.6.1.4.1.19376.1.3.3.2.2 | | Laboratory Report Item Section (LAB TF-3, Revision 6.0 - Final Text, July 14, 2015) | 2016‑06‑24 12:44:54 |
1.3.6.1.4.1.19376.1.3.10.2.5 | Containment | CDA participant Pertinent Insurance Information | 2017‑11‑13 15:46:20 |
1.3.6.1.4.1.19376.1.3.10.2.5 | Containment | CDA participant Pertinent Insurance Information | 2017‑11‑13 15:51:57 |
1.3.6.1.4.1.19376.1.3.10.2.5 | Containment | Participant Pertinent Insurance Information | 2017‑11‑13 16:52:30 |
1.3.6.1.4.1.19376.1.3.10.3.1 | | Additional Specified Observation Section (2.0) | 2016‑11‑13 14:28:08 |
1.3.6.1.4.1.19376.1.3.10.4.1 | | Specimen Procedure Step (1.0) | 2014‑07‑29 16:02:02 |
1.3.6.1.4.1.19376.1.3.10.4.1 | | Specimen Procedure Step (2.0) | 2016‑07‑08 13:20:59 |
1.3.6.1.4.1.19376.1.3.10.4.2 | | UICC/AJCC TNM Staging and Grading Observation (2.0) | 2014‑05‑13 15:45:13 |
1.3.6.1.4.1.19376.1.3.10.4.3 | | ICD-O-3 Typing and Grading Observation (2.0) | 2015‑11‑29 17:03:18 |
1.3.6.1.4.1.19376.1.3.10.4.4 | | CDA Supply Container APSR2 (1.0) | 2016‑07‑29 |
1.3.6.1.4.1.19376.1.3.10.4.4 | | Assessment Scales for Scoring Systems APSR2 (1.9) | 2016‑10‑06 12:36:29 |
1.3.6.1.4.1.19376.1.3.10.4.4 | | Assessment Scales Observation for Scoring Systems (2.0) | 2016‑10‑06 13:12:00 |
1.3.6.1.4.1.19376.1.3.10.4.5 | | Update Information Organizer (2.0) | 2017‑11‑14 15:22:14 |
1.3.6.1.4.1.19376.1.3.10.9.22 | | Specimen Container in Procedure Step (2.0) | 2016‑07‑29 12:09:33 |
1.3.6.1.4.1.19376.1.3.10.9.25 | | TNM T-Observation (2.0) | 2014‑12‑02 15:54:17 |
1.3.6.1.4.1.19376.1.3.10.9.26 | | TNM N-Observation (2.0) | 2014‑12‑02 16:34:50 |
1.3.6.1.4.1.19376.1.3.10.9.27 | | TNM M-Observation (2.0) | 2014‑12‑02 16:32:30 |
1.3.6.1.4.1.19376.1.3.10.9.28 | | TNM Grading (2.0) | 2015‑11‑15 13:01:18 |
1.3.6.1.4.1.19376.1.3.10.9.29 | | TNM R-status (2.0) | 2015‑06‑30 13:38:30 |
1.3.6.1.4.1.19376.1.3.10.9.30 | | TNM a (2.0) | 2015‑06‑22 15:13:46 |
1.3.6.1.4.1.19376.1.3.10.9.31 | | TNM r (2.0) | 2015‑06‑22 17:38:42 |
1.3.6.1.4.1.19376.1.3.10.9.32 | | TNM y (2.0) | 2015‑06‑22 17:28:17 |
1.3.6.1.4.1.19376.1.3.10.9.33 | | TNM Serum tumor markers (2.0) | 2015‑11‑06 14:28:44 |
1.3.6.1.4.1.19376.1.3.10.9.34 | | TNM Lymphatic Invasion (2.0) | 2015‑11‑16 14:01:58 |
1.3.6.1.4.1.19376.1.3.10.9.35 | | TNM Venous Invasion (2.0) | 2015‑11‑16 13:40:28 |
1.3.6.1.4.1.19376.1.3.10.9.36 | | TNM Perineural Invasion (2.0) | 2015‑11‑11 16:13:40 |
1.3.6.1.4.1.19376.1.3.10.9.37 | | TNM Number of nodes (2.0) | 2014‑12‑02 16:48:36 |
1.3.6.1.4.1.19376.1.3.10.9.42 | | Assessment Scoring System APSR 2.0 (2.0) | 2016‑10‑10 11:33:36 |
1.3.6.1.4.1.19376.1.3.10.9.43 | | Assessment Scoring Item APSR 2.0 (2.0) | 2016‑10‑11 10:26:17 |
1.3.6.1.4.1.19376.1.4.1.3.8 | Containment | author - Cardiac (1.0) | 2017‑03‑24 16:46:04 |
1.3.6.1.4.1.19376.1.8.1.1.1 | | Anatomic Pathology Structured Report Content Module (2.0) | 2014‑05‑13 11:57:57 |
1.3.6.1.4.1.19376.1.8.1.2.1 | | Clinical Information Section (2.0) | 2014‑05‑13 14:38:08 |
1.3.6.1.4.1.19376.1.8.1.2.2 | | Intraoperative Observation Section (2.0) | 2014‑05‑13 19:29:16 |
1.3.6.1.4.1.19376.1.8.1.2.3 | | Macroscopic Observation Section (2.0) | 2014‑05‑13 11:57:09 |
1.3.6.1.4.1.19376.1.8.1.2.4 | | Microscopic Observation Section (2.0) | 2014‑05‑13 14:25:17 |
1.3.6.1.4.1.19376.1.8.1.2.5 | | Diagnostic Conclusion Section (2.0) | 2014‑05‑13 19:31:26 |
1.3.6.1.4.1.19376.1.8.1.2.6 | | Procedure Steps Section (2.0) | 2014‑05‑13 19:33:12 |
1.3.6.1.4.1.19376.1.8.1.3.6 | | Problem Organizer (2.0) | 2015‑08‑13 10:24:55 |
1.3.6.1.4.1.19376.1.8.1.4.1 | Containment | Specimen Collector in Header | 2016‑06‑13 14:21:13 |
1.3.6.1.4.1.19376.1.8.1.4.2 | Inklusion | Author (2.0) | 2016‑06‑21 14:02:11 |
1.3.6.1.4.1.19376.1.8.1.4.3 | | Content Validator | 2016‑07‑09 15:03:59 |
1.3.6.1.4.1.19376.1.8.1.4.6 | | Informant (2.0) | 2016‑07‑08 11:22:58 |
1.3.6.1.4.1.19376.1.8.1.4.9 | | AP Observation Entry (2.0) | 2014‑05‑14 17:09:54 |
1.3.6.1.4.1.19376.1.8.1.4.10 | | Embedded Image | 2016‑06‑22 16:08:01 |
1.3.6.1.4.1.19376.1.9.1.2.1 | | IHE Prescription Section Content Module (PRE 2017) | 2018‑01‑10 11:13:04 |
1.3.6.1.4.1.19376.1.9.1.2.2 | | IHE Pharmaceutical Advice Section Content Moudule (PADV 2017) | 2018‑01‑10 11:13:04 |
1.3.6.1.4.1.19376.1.9.1.2.3 | | IHE Dispense Section Content Module (DIS 2017) | 2018‑01‑10 11:13:04 |
1.3.6.1.4.1.19376.1.9.1.2.5 | | IHE Medication List Section Content Module (PML 2017) | 2018‑01‑10 08:39:19 |
1.3.6.1.4.1.19376.1.9.1.2.6 | | IHE Medication Treatment Plan Section Content Module (2021) | 2017‑04‑03 07:47:01 |
2.16.756.5.30.1.1.10.1.2 | | EmergencyMedicalServiceProtocol (2017) | 2017‑05‑31 17:19:29 |
2.16.756.5.30.1.1.10.1.9 | | CDA-CH v2.1 - structuredBody (2020) | 2019‑10‑17 15:22:41 |
2.16.756.5.30.1.1.10.1.14 | | CDA-CH v2.0 - structuredBody enhanced (2018) | 2018‑04‑18 |
2.16.756.5.30.1.1.10.2.38 | | Component Of (2017) | 2017‑07‑10 23:38:32 |
2.16.756.5.30.1.1.10.4.54 | | Mission Encounter (2017) | 2017‑07‑11 09:40:49 |
2.16.756.5.30.1.1.10.9.36 | | CDA-CH v2.0 Header Template Compilation (2017) | 2018‑04‑18 |
2.16.756.5.30.1.1.10.9.40 | | RESP Header Template Compilation (2017) | 2017‑11‑20 13:35:46 |
2.16.756.5.30.1.1.10.9.41 | | Header Template Compilation Medication Dispense document (2019) | 2018‑01‑08 15:56:47 |
2.16.756.5.30.1.1.10.9.42 | | Header Template Compilation Medication Card document (2017) | 2018‑01‑08 16:20:12 |
2.16.756.5.30.1.1.10.9.42 | | Header Template Compilation Medication Card document (2022) | 2019‑10‑17 13:58:45 |
2.16.756.5.30.1.1.10.9.43 | | Header Template Compilation Pharmaceutical Advice document (2019) | 2018‑01‑08 16:23:16 |
2.16.756.5.30.1.1.10.9.44 | | Header Template Compilation MedicationTreatmentPlan (2019) | 2018‑01‑08 16:26:11 |
2.16.756.5.30.1.1.10.9.45 | | Header Template Compilation Medication Prescription document (2021) | 2018‑01‑08 16:28:39 |
2.16.756.5.30.1.1.10.9.46 | | Header Template Compilation Medication List document (2019) | 2018‑01‑22 15:29:29 |
2.16.756.5.30.1.127.10.1.3 | | Laborbefund Transplantationsprozesss | 2017‑08‑14 |
2.16.840.1.113883.2.6.60.2.10.3 | | XXX CDA | 2014‑06‑27 21:01:53 |
2.16.840.1.113883.2.6.60.2.10.3001 | | NFD Section Allergien, Unverträglichkeiten | 2014‑06‑29 13:35:11 |
2.16.840.1.113883.2.6.60.2.10.3003 | | NFD Section Implantate | 2014‑06‑29 13:40:56 |
2.16.840.1.113883.2.6.60.2.10.3003 | | NFD Section Diagnosen | 2014‑06‑29 15:31:54 |
2.16.840.1.113883.2.6.60.2.10.3005 | | NFD Section Schwangerschaft | 2014‑07‑07 14:19:33 |
2.16.840.1.113883.2.6.60.2.10.3006 | | NFD Section Risiken Ressourcen | 2014‑07‑07 14:32:47 |
2.16.840.1.113883.2.6.60.2.10.4002 | | NFD Entry Observation | 2014‑06‑29 13:55:47 |
2.16.840.1.113883.2.6.60.2.10.4002 | | NFD Entry Observation | 2014‑07‑07 12:54:09 |
2.16.840.1.113883.2.6.60.2.10.4003 | | NFD Entry Concern | 2014‑07‑02 15:10:03 |
2.16.840.1.113883.2.6.60.2.10.4003 | | NFD Entry Concern | 2014‑07‑02 23:36:34 |
2.16.840.1.113883.2.6.60.2.10.4004 | | NFD Entry Problem | 2014‑07‑02 15:11:28 |
2.16.840.1.113883.2.6.60.2.10.4004 | | NFD Entry Problem | 2014‑07‑02 23:34:57 |
2.16.840.1.113883.2.6.60.2.10.4004 | | NFD Entry Problem | 2014‑07‑07 15:57:16 |
2.16.840.1.113883.2.6.60.2.10.4004 | | NFD Entry Problem | 2014‑07‑07 15:57:17 |
2.16.840.1.113883.2.6.60.2.10.4005 | | NFD Entry Medikation Verordnung | 2014‑07‑02 14:54:43 |
2.16.840.1.113883.2.6.60.2.10.900214 | | XXX Informant Versicherter | 2014‑06‑29 14:05:18 |
2.16.840.1.113883.2.6.60.2.10.900216 | | xxx Informant (Body) | 2014‑06‑29 14:10:03 |
2.16.840.1.113883.2.6.60.2.10.900218 | Containment | xxx AssignedEntity | 2014‑06‑29 14:21:40 |
2.16.840.1.113883.2.6.60.2.10.900224 | Containment | xxx Behandelnder Arzt | 2014‑06‑29 21:39:12 |
2.16.840.1.113883.2.6.60.2.10.900229 | | yy CDA Informant (Body) 1 | 2014‑07‑02 20:51:36 |
2.16.840.1.113883.2.6.60.3.10.1 | | CDA SubstanceAdministration | 2016‑04‑22 10:50:09 |
2.16.840.1.113883.2.6.60.6.10.45 | | Elston-Ellis-Grading | 2016‑05‑24 21:55:39 |
2.16.840.1.113883.2.6.60.6.10.49 | | CDA legalAuthenticator IHE | 2016‑07‑09 15:09:10 |
2.16.840.1.113883.2.6.60.6.10.51 | Containment | CDA informationRecipient IHE (0.1) | 2016‑07‑09 15:17:23 |
2.16.840.1.113883.2.9.10.1.6.19 | | VPS documentationOf | 2017‑04‑20 11:46:09 |
2.16.840.1.113883.2.9.10.1.6.21 | | VPS Sezione Triage | 2017‑04‑20 12:01:43 |
2.16.840.1.113883.2.9.10.1.6.22 | | Z-Temp VPS Sezione Visita | 2017‑04‑20 12:12:06 |
2.16.840.1.113883.2.9.10.1.6.23 | | VPS Sezione Decorso Clinico | 2017‑04‑20 14:10:52 |
2.16.840.1.113883.2.9.10.1.6.24 | | VPS Sezione Dimissione | 2017‑04‑20 14:23:41 |
2.16.840.1.113883.2.9.10.1.6.25 | | VPS Sezione Richieste | 2017‑04‑20 14:25:04 |
2.16.840.1.113883.2.9.10.1.6.26 | | VPS Sezione Interventi, Prestazioni, Consulenze e Richieste | 2017‑04‑20 14:35:16 |
2.16.840.1.113883.2.9.10.1.6.27 | | VPS Sezione Accertamenti | 2017‑04‑20 14:44:10 |
2.16.840.1.113883.2.9.10.1.6.30 | | VPS Sezione Dati Amministrativi | 2017‑04‑20 14:51:06 |
2.16.840.1.113883.2.9.10.1.6.33 | | VPS Sezione Allergie | 2017‑04‑27 16:39:36 |
2.16.840.1.113883.2.9.10.1.6.34 | | VPS Sezione Piano di Cura | 2017‑04‑27 17:30:18 |
2.16.840.1.113883.2.9.10.1.6.43 | | CDA Observation | 2017‑05‑04 18:42:02 |
2.16.840.1.113883.2.9.10.1.6.45 | | VPS Organizer Accertamenti | 2017‑05‑20 08:07:50 |
2.16.840.1.113883.2.9.10.1.6.52 | | VPS Terapie Farmacologiche (SBADM) | 2017‑05‑20 17:09:55 |
2.16.840.1.113883.2.9.10.1.6.55 | | VPS Sezione Anamnesi | 2017‑05‑22 14:58:22 |
2.16.840.1.113883.2.9.10.1.6.56 | | VPS Sezione Inquadramento Iniziale | 2017‑05‑22 16:21:59 |
2.16.840.1.113883.2.9.10.1.6.58 | | VPS Sezione Esame Obiettivo | 2017‑05‑22 16:49:42 |
2.16.840.1.113883.2.9.10.1.6.59 | | VPS Sezione Lista Problemi | 2017‑05‑22 17:02:11 |
2.16.840.1.113883.2.9.10.1.6.60 | | VPS Problem Concern Act | 2017‑05‑22 17:18:05 |
2.16.840.1.113883.2.9.10.1.6.61 | | VPS Problem Observation | 2017‑05‑22 17:34:22 |
2.16.840.1.113883.2.9.10.1.6.62 | | VPS Interventi, Prestazioni e Consulenze (Act) | 2017‑05‑23 09:24:54 |
2.16.840.1.113883.2.9.10.1.6.74 | | VPS Sezione Terapie Farmacologiche alla dimissione | 2017‑05‑27 07:59:28 |
2.16.840.1.113883.2.9.10.1.6.80 | Containment | CDA Author (Body) | 2017‑05‑28 18:36:25 |
2.16.840.1.113883.2.9.10.1.6.83 | | VPS Disturbo Riportato Observation | 2017‑07‑06 18:06:46 |
2.16.840.1.113883.2.9.10.1.10.2 | | Sezione Esenzioni | 2018‑05‑21 15:49:16 |
2.16.840.1.113883.2.9.10.1.10.3 | | Act Esenzione | 2018‑05‑21 15:56:46 |
2.16.840.1.113883.2.9.77.1.10.900204 | | Motivo del ricovero | 2015‑02‑02 12:56:24 |
2.16.840.1.113883.2.9.77.1.10.900214 | | Condizioni e Diagnosi alla dimissione | 2015‑02‑02 14:07:35 |
2.16.840.1.113883.2.9.77.1.10.900238 | | CDA Observation | 2016‑05‑28 22:16:29 |
2.16.840.1.113883.2.51.10.1.2.1 | | XeH Header | 2021‑06‑30 12:15:42 |
2.16.840.1.113883.2.51.10.2 | | XeH Diagnostic Imaging Report (1.0) | 2021‑06‑21 14:23:14 |
2.16.840.1.113883.2.51.10.2 | | XeH Diagnostic Imaging Report (1.1) | 2023‑12‑13 17:06:14 |
2.16.840.1.113883.2.51.10.3.10 | | PCSP Plan of Care Section | 2021‑08‑02 10:32:04 |
2.16.840.1.113883.2.51.10.4 | | XeH Clinical Document (1.0) | 2021‑09‑07 16:23:15 |
2.16.840.1.113883.2.51.10.10 | | XeH ComponentOf (1.0) | 2021‑09‑07 18:27:26 |
2.16.840.1.113883.2.51.10.12 | | XeH Hospital Discharge Report (1.0) | 2021‑09‑10 14:49:32 |
2.16.840.1.113883.2.51.10.15 | | XeH Patient History Section (1.0) | 2021‑09‑10 15:17:23 |
2.16.840.1.113883.2.51.10.16 | | XeH Family History Section (1.0) | 2021‑09‑10 15:22:07 |
2.16.840.1.113883.2.51.10.23 | | XeH Problems Section (1.0) | 2021‑09‑22 17:29:31 |
2.16.840.1.113883.2.51.10.38 | | XeH Care Provision Act | 2021‑10‑18 16:17:01 |
2.16.840.1.113883.2.51.10.41 | | XeH Medication Summary Section (1.0) | 2021‑10‑19 11:12:56 |
2.16.840.1.113883.2.51.10.49 | | XeH HDR ComponentOf (1.0) | 2021‑12‑03 11:50:16 |
2.16.840.1.113883.2.51.10.52 | | XeH Infectious Contact Section (1.0) | 2022‑01‑14 10:50:11 |
2.16.840.1.113883.2.51.10.57 | | XeH History of Past Illness Section (1.0) | 2022‑02‑18 09:12:34 |
2.16.840.1.113883.2.51.10.64 | | XeH Immunization (1.0) | 2022‑05‑06 09:23:08 |
2.16.840.1.113883.2.51.10.65 | | XeH Immunizations Section (1.0) | 2022‑05‑06 09:34:10 |
2.16.840.1.113883.2.51.10.71 | | XeH Lab ComponentOf (1.0) | 2022‑05‑23 10:20:45 |
2.16.840.1.113883.2.51.10.82 | | XeH Vital Signs Section (1.0) | 2022‑06‑24 14:17:33 |
2.16.840.1.113883.3.51.60.1.10 | | BC CDA documentationOf | 2016‑03‑27 09:05:07 |
2.16.840.1.113883.3.51.60.1.11 | | BC CDA componentOf | 2016‑03‑27 09:09:45 |
2.16.840.1.113883.3.51.60.2.0 | | BC CDA Clinical Document Header | 2016‑04‑03 18:54:58 |
2.16.840.1.113883.3.51.60.3.3 | | BC CDA StructuredBody | 2016‑04‑04 16:51:10 |
2.16.840.1.113883.3.1818.10.1.2.1 | | BC CDA ClinicalDocumentGenericEpisodic | 2016‑11‑28 15:06:29 |
2.16.840.1.113883.3.1818.10.1.3.1 | | BC CDA ClinicalDocumentPatientTransfer | 2017‑03‑30 10:51:43 |
2.16.840.1.113883.3.1818.10.1.4 | | BC CDA E2E Unstructured Document | 2017‑04‑04 15:33:33 |
2.16.840.1.113883.3.1818.10.1.4 | | BC CDA E2E Unstructured Document | 2017‑04‑04 20:39:19 |
2.16.840.1.113883.3.1818.10.1.5 | | BC CDA E2E Unstructured Referral | 2017‑04‑04 21:10:18 |
2.16.840.1.113883.3.1818.10.1.7.1 | | BC CDA ClinicalDocumentStructuredConsultReport | 2016‑12‑01 21:39:19 |
2.16.840.1.113883.3.1818.10.3.3 | | BC Allergy Intolerance Observation Act | 2017‑04‑02 06:50:15 |
2.16.840.1.113883.3.1818.10.3.3 | | BC Allergy Intolerance Observation Act | 2017‑04‑02 08:00:43 |
2.16.840.1.113883.3.1818.10.3.3 | | BC Allergy Intolerance Observation Act | 2017‑04‑02 08:08:32 |
2.16.840.1.113883.3.1818.10.3.9 | | BC Encounter Event | 2017‑04‑02 22:14:30 |
2.16.840.1.113883.3.1818.10.4.7 | | BC Medication Dispense Event | 2017‑04‑01 05:18:24 |
2.16.840.1.113883.3.1818.10.4.20 | | BC Medication Prescription Event | 2017‑04‑01 06:19:37 |
2.16.840.1.113883.3.1818.10.4.24 | | BC Reason Observation | 2017‑04‑01 05:57:31 |
2.16.840.1.113883.3.1818.10.4.30 | | BC Severity Observation | 2017‑04‑01 22:54:28 |
2.16.840.1.113883.3.1818.10.4.37 | | BC Order Indicator | 2017‑04‑01 05:39:26 |
2.16.840.1.113883.3.1818.10.4.38 | | BC Record ID Link | 2017‑04‑01 05:48:33 |
2.16.840.1.113883.3.1818.10.7.1 | | BC CDA E2E Clinical Document Header | 2017‑03‑31 00:20:01 |
2.16.840.1.113883.3.1937.99.60.7.10.4.1 | | Immunization | 2017‑03‑08 |
2.16.840.1.113883.3.1937.99.61.5.10.900213 | Containment | CDA recordTarget222 | 2013‑11‑14 20:07:27 |
2.16.840.1.113883.3.1937.99.61.5.10.900216 | | CDA Observation | 2013‑12‑04 10:55:24 |
2.16.840.1.113883.3.1937.99.61.5.10.900239 | | eLab_Specimen Received_ | 2014‑01‑14 14:12:16 |
2.16.840.1.113883.3.1937.99.61.5.10.900240 | | eLab_Specimen Received_ | 2014‑01‑14 14:12:39 |
2.16.840.1.113883.3.1937.99.61.5.10.900241 | | eLab_Specimen Received_ | 2014‑01‑14 14:13:27 |
2.16.840.1.113883.3.1937.99.61.5.10.900242 | | eLab_Specimen Received_ | 2014‑01‑14 14:13:28 |
2.16.840.1.113883.3.1937.99.61.5.10.900243 | | eLab_Specimen Received_ | 2014‑01‑14 14:13:28 |
2.16.840.1.113883.3.1937.99.61.5.10.900244 | | eLab_Specimen Received_ | 2014‑01‑14 14:13:29 |
2.16.840.1.113883.3.1937.99.61.5.10.900245 | | eLab_Specimen Received_ | 2014‑01‑14 14:13:29 |
2.16.840.1.113883.3.1937.99.61.5.10.900246 | | eLab_Specimen Received_ | 2014‑01‑14 14:13:29 |
2.16.840.1.113883.3.1937.99.61.5.10.900247 | | eLab_Specimen Received_ | 2014‑01‑14 14:13:30 |
2.16.840.1.113883.3.1937.99.61.5.10.900265 | | CDA Organizer | 2014‑01‑14 14:17:08 |
2.16.840.1.113883.3.1937.99.61.5.10.900273 | | Anatomic Pathology Structured Report | 2014‑05‑13 11:57:57 |
2.16.840.1.113883.3.1937.99.61.5.10.900275 | | APSR2 Clinical Information Section | 2014‑05‑13 14:38:08 |
2.16.840.1.113883.3.1937.99.61.5.10.900276 | | TNM Observation | 2014‑05‑13 15:45:13 |
2.16.840.1.113883.3.1937.99.61.5.10.900277 | | APSR2 Intraoperative Observation Section | 2014‑05‑13 19:29:16 |
2.16.840.1.113883.3.1937.99.61.5.10.900278 | | APSR2 Diagnostic Conclusion Section | 2014‑05‑13 19:31:26 |
2.16.840.1.113883.3.1937.99.61.5.10.900280 | | APSR2 AP Observation Entry | 2014‑05‑14 17:09:54 |
2.16.840.1.113883.3.1937.99.61.5.10.900283 | | APSR2 Specimen procedure step Entry | 2014‑07‑29 16:02:02 |
2.16.840.1.113883.3.1937.99.61.5.10.900286 | | einheitlicher onkologischer Basisdatensatz | 2014‑12‑01 15:14:45 |
2.16.840.1.113883.3.1937.99.61.5.10.900290 | | ADT-Tod | 2014‑12‑02 09:05:37 |
2.16.840.1.113883.3.1937.99.61.5.10.900293 | | ADT Tod | 2014‑12‑02 11:02:38 |
2.16.840.1.113883.3.1937.99.61.5.10.900296 | | TNM M-Observation | 2014‑12‑02 16:32:30 |
2.16.840.1.113883.3.1937.99.61.5.10.900304 | | APSR2 Specimen Organizer | 2014‑12‑22 17:58:40 |
2.16.840.1.113883.3.1937.99.61.5.10.900305 | | IHE Electrophysiology Implant/Explant Report Content (EPRC-IE) | 2015‑03‑03 16:17:56 |
2.16.840.1.113883.3.1937.99.61.5.10.900311 | | CDA SubstanceAdministration | 2018‑08‑02 12:16:53 |
2.16.840.1.113883.3.1937.99.61.5.10.900312 | | CDA SubstanceAdministration | 2018‑08‑02 12:18:33 |
2.16.840.1.113883.3.1937.99.61.5.10.900316 | Containment | CDA participant | 2021‑04‑13 20:50:09 |
2.16.840.1.113883.3.1937.99.61.15.10.900202 | | Andrew CDA Test Document (1.0) | 2015‑02‑13 20:52:59 |
2.16.840.1.113883.3.1937.99.61.15.10.900205 | | pCSCDAHeader (2015-01-30) | 2015‑03‑18 14:57:09 |
2.16.840.1.113883.3.1937.99.61.15.10.900205 | | pCSCDAHeader (2015-03-19) | 2015‑03‑19 16:46:00 |
2.16.840.1.113883.3.1937.99.61.15.10.900205 | | pCSCDAHeader (2015-04-28) | 2015‑04‑28 23:29:35 |
2.16.840.1.113883.3.1937.99.61.15.10.900208 | | Canada CDA Header (20150429) | 2015‑04‑29 22:30:07 |
2.16.840.1.113883.3.1937.99.61.16.10.9 | | CDA ClinicalDocumentTesti | 2019‑05‑16 11:00:30 |
2.16.840.1.113883.3.1937.99.61.16.10.10 | | CDA ClinicalDocumentMikaTesti | 2019‑05‑16 11:05:40 |
2.16.840.1.113883.3.1937.99.61.17.10.1 | | Heart Failure ClinicalDocument | 2015‑05‑09 10:51:13 |
2.16.840.1.113883.3.1937.99.61.18.10.6 | | Выписной эпикриз | 2015‑06‑06 14:32:25 |
2.16.840.1.113883.3.1937.99.61.18.10.8 | Containment | CDA recordTarget | 2021‑02‑17 18:58:24 |
2.16.840.1.113883.3.1937.99.61.18.10.14 | | CDA Performer (Body) | 2021‑02‑26 17:26:17 |
2.16.840.1.113883.3.1937.99.61.18.10.15 | Containment | CDA AssignedEntity | 2021‑02‑26 17:30:30 |
2.16.840.1.113883.3.1937.99.61.18.10.17 | Containment | CDA recordTarget2 | 2021‑04‑05 17:22:16 |
2.16.840.1.113883.3.1937.99.61.19.10.24 | | CDA Observation1 | 2017‑08‑10 15:15:49 |
2.16.840.1.113883.3.1937.99.61.19.10.71 | | Ambulanzbefund | 2019‑05‑10 08:58:00 |
2.16.840.1.113883.3.1937.99.61.19.10.78 | | TEST_AKL_Ambulanzbefund (2020) | 2020‑02‑05 15:44:24 |
2.16.840.1.113883.3.1937.99.61.19.10.78 | | TEST_AKL_Ambulanzbefund (2020.1) | 2020‑11‑25 10:42:33 |
2.16.840.1.113883.3.1937.99.61.20.10.1 | Containment | CDA recordTarget (not used) | 2015‑10‑29 09:13:22 |
2.16.840.1.113883.3.1937.99.61.21.10.2 | | BC trial template ClinicalDocument nonXMLbody | 2016‑10‑21 19:38:13 |
2.16.840.1.113883.3.1937.99.61.21.10.23 | | Pan-Canadian Header Practice (0.01) | 2019‑09‑11 01:40:57 |
2.16.840.1.113883.3.1937.99.61.21.10.47 | | NH v2 to CDA Mapping | 2019‑09‑17 01:12:11 |
2.16.840.1.113883.3.1937.99.61.21.10.51 | | BC CDA MedicalImaging | 2020‑06‑13 00:18:42 |
2.16.840.1.113883.3.1937.99.61.21.10.75 | | Radiology Comparison Study - Observation | 2020‑08‑11 20:29:30 |
2.16.840.1.113883.3.1937.99.61.26.10.46 | | CDA ClinicalDocument | 2017‑03‑08 00:38:01 |
2.16.840.1.113883.3.1937.99.61.27.10.3 | | tsc_test_CDASection | 2016‑05‑27 11:53:53 |
2.16.840.1.113883.3.1937.99.61.27.10.4 | | Laboratory Specialty Text and Entry (LAB TF-3, Revision 6.0 - Final Text, July 14, 2015) | 2016‑06‑24 12:40:20 |
2.16.840.1.113883.3.1937.99.61.27.10.11 | | CDA Observation | 2018‑11‑13 14:00:31 |
2.16.840.1.113883.3.1937.99.61.27.10.12 | | JBl_CDA Observation (JBL-V1) | 2018‑11‑13 14:14:08 |
2.16.840.1.113883.3.1937.99.61.27.10.13 | | NewTemplate (V0) | 2018‑11‑13 14:14:16 |
2.16.840.1.113883.3.1937.99.61.27.10.14 | | JBl_CDA Observation (JBL-V1) | 2018‑11‑13 14:14:49 |
2.16.840.1.113883.3.1937.99.61.27.10.15 | | PGRNewTemplateTest (V0) | 2018‑11‑13 14:17:21 |
2.16.840.1.113883.3.1937.99.61.27.10.16 | | NewTemplate (V0) | 2018‑11‑13 14:17:38 |
2.16.840.1.113883.3.1937.99.61.27.10.17 | | CDA ClinicalDocument (with StructuredBody) | 2019‑08‑22 09:46:40 |
2.16.840.1.113883.3.1937.99.61.27.10.18 | | CDA ClinicalDocument (with StructuredBody) | 2019‑08‑22 09:46:48 |
2.16.840.1.113883.3.1937.99.61.27.10.19 | | FLM_SupplyOneRelationShipSubstanceAdministration (2019) | 2019‑08‑29 14:54:39 |
2.16.840.1.113883.3.1937.99.61.27.10.20 | | FLM_SubstanceAdministration | 2019‑08‑29 15:03:30 |
2.16.840.1.113883.3.1937.99.61.27.10.21 | | FLM_Supply | 2019‑08‑29 15:51:42 |
2.16.840.1.113883.3.1937.99.61.27.10.22 | | FLM_SubstanceAdministration2 | 2019‑09‑01 21:32:53 |
2.16.840.1.113883.3.1937.99.61.27.10.23 | | FLM_SupplyTwoRelationShipToSubstanceAdministration | 2019‑09‑01 21:33:57 |
2.16.840.1.113883.3.1937.99.61.28.10.4 | | CDA Nivel 1 (1) | 2017‑04‑22 23:33:51 |
2.16.840.1.113883.3.1937.99.61.28.10.5 | | Header CDA Minimo (1) | 2017‑09‑03 16:34:55 |
2.16.840.1.113883.3.1937.99.61.30.10.59 | | _Immunization (harmonization) | 2021‑06‑23 19:42:25 |
2.16.840.1.113883.3.1937.99.61.30.10.63 | Containment | CDA recordTarget | 2022‑06‑13 13:06:24 |
2.16.840.1.113883.3.1937.99.61.30.10.64 | | Prescrizione specialistica (with StructuredBody) (1.0) | 2022‑06‑13 15:50:01 |
2.16.840.1.113883.3.1937.99.61.30.10.65 | | Prescrizione farmaceutica (with StructuredBody) (1.0) | 2022‑06‑13 17:14:33 |
2.16.840.1.113883.3.1937.99.61.30.10.66 | Containment | CDA2 recordTarget | 2022‑06‑14 11:23:31 |
2.16.840.1.113883.3.1937.99.61.30.10.67 | Containment | CDA2 recordTarget | 2022‑06‑14 11:23:45 |
2.16.840.1.113883.3.1937.99.61.30.10.68 | Containment | CDA2 author | 2022‑06‑14 12:05:30 |
2.16.840.1.113883.3.1937.99.61.30.10.69 | | CDA2 dataEnterer | 2022‑06‑14 12:13:07 |
2.16.840.1.113883.3.1937.99.61.30.10.71 | Containment | CDA2 informationRecipient | 2022‑06‑14 12:33:33 |
2.16.840.1.113883.3.1937.99.61.30.10.72 | | CDA2 legalAuthenticator | 2022‑06‑14 12:37:54 |
2.16.840.1.113883.3.1937.99.61.30.10.73 | | CDA2 authenticator | 2022‑06‑14 12:42:51 |
2.16.840.1.113883.3.1937.99.61.30.10.74 | Containment | CDA2 participant | 2022‑06‑14 12:49:46 |
2.16.840.1.113883.3.1937.99.61.30.10.76 | | CDA2 documentationOf | 2022‑06‑14 15:22:59 |
2.16.840.1.113883.3.1937.99.61.30.10.78 | | CDA2 componentOf | 2022‑06‑14 15:41:13 |
2.16.840.1.113883.3.1937.99.61.30.10.79 | | CDA2 Informant | 2022‑06‑14 15:45:43 |
2.16.840.1.113883.3.1937.99.61.31.10.1.2 | | My Section | 2014‑02‑08 16:16:07 |
2.16.840.1.113883.3.1937.99.61.32.10.23 | | CDA ClinicalDocument (with StructuredBody) | 2017‑06‑21 14:48:45 |
2.16.840.1.113883.3.1937.99.61.38.10.1 | | F2102 Entlassungsbericht | 2017‑11‑08 09:57:50 |
2.16.840.1.113883.3.1937.99.61.38.10.19 | | Darreichungsform | 2018‑02‑06 09:41:53 |
2.16.840.1.113883.3.1937.99.61.38.10.20 | | Arzneimittel | 2018‑02‑06 09:45:28 |
2.16.840.1.113883.3.1937.99.61.45.10.3 | Containment | CDA author t | 2018‑04‑16 10:24:11 |
2.16.840.1.113883.3.1937.99.61.45.10.4 | | CDA ClinicalDocument T | 2018‑04‑16 10:35:28 |
2.16.840.1.113883.3.1937.99.61.45.10.5 | | CDA Section t | 2018‑04‑16 11:44:27 |
2.16.840.1.113883.3.1937.99.61.45.10.6 | | CDA Observation t | 2018‑04‑16 12:13:51 |
2.16.840.1.113883.3.1937.99.61.45.10.16 | | Adipositas Studie | 2018‑04‑24 10:33:11 |
2.16.840.1.113883.3.1937.99.61.45.10.17 | | CDA Adipositas Studie | 2018‑04‑24 10:41:37 |
2.16.840.1.113883.3.1937.99.61.45.10.37 | | Dok3 Sonstiges | 2018‑05‑02 17:52:41 |
2.16.840.1.113883.3.1937.99.61.45.10.39 | | Dok3 kleines Blutbild ? | 2018‑05‑02 17:58:11 |
2.16.840.1.113883.3.1937.99.61.45.10.50 | | ASIC weitere Vitaldaten | 2018‑05‑08 16:29:04 |
2.16.840.1.113883.3.1937.99.61.45.10.62 | | CDA Observation | 2018‑08‑28 13:22:11 |
2.16.840.1.113883.3.1937.99.61.48.10.25 | Containment | Pflegearzt (Kurator) | 2019‑08‑22 11:16:37 |
2.16.840.1.113883.3.1937.99.61.53.10.78 | | (AU-BF) Bericht bei Fortbestehen der AU | 2019‑09‑19 13:42:22 |
2.16.840.1.113883.3.1937.99.61.53.10.138 | | (WE) Wiedereingliederung Erwerbsleben | 2019‑10‑06 15:43:10 |
2.16.840.1.113883.3.1937.99.61.53.10.178 | | (HV) Heilmittelverordnung | 2019‑11‑25 11:56:41 |
2.16.840.1.113883.3.1937.99.61.53.10.224 | | (HV-2019) Heilmittelverordnung | 2020‑01‑31 17:17:34 |
2.16.840.1.113883.3.1937.99.61.53.10.230 | | (KB) Krankenhausbehandlung | 2020‑05‑04 17:39:18 |
2.16.840.1.113883.3.1937.99.61.66.10.1 | | CDA ClinicalDocument | 2020‑07‑31 11:03:27 |
2.16.840.1.113883.3.1937.99.61.66.10.2 | | CDA ClinicalDocument (GReg) | 2020‑07‑31 16:48:37 |
2.16.840.1.113883.3.1937.99.61.67.10.7 | | XeH ComponentOf (wip) | 2020‑10‑02 14:47:14 |
2.16.840.1.113883.3.1937.99.61.67.10.8 | | XeH Hospital Discharge Report (0.1) | 2020‑10‑02 15:17:28 |
2.16.840.1.113883.3.1937.99.61.67.10.17 | | CDA ClinicalDocument | 2020‑12‑09 11:44:45 |
2.16.840.1.113883.3.1937.99.61.67.10.18 | | XeH Clinical Document | 2020‑12‑09 11:45:40 |
2.16.840.1.113883.3.1937.99.61.67.10.19 | | XeH ComponentOf HDR (wip) | 2021‑03‑04 15:37:57 |
2.16.840.1.113883.3.1937.99.61.67.10.29 | | XeH Problems Section (0.1) | 2021‑04‑29 15:13:06 |
2.16.840.1.113883.3.1937.777.17.10.1 | Containment | BC CDA Author (Body) | 2017‑03‑29 17:54:30 |
2.16.840.1.113883.3.1937.777.17.10.36 | | BC CDA E2E EMR Conversion | 2017‑04‑02 07:42:02 |
2.16.840.1.113883.3.1937.777.17.10.47 | | BC CDA Organizer | 2017‑04‑02 19:50:56 |
2.16.840.1.113883.3.1937.777.17.10.48 | | BC Clinically Measured Observations Organizer | 2017‑04‑02 19:58:41 |
2.16.840.1.113883.3.1937.777.17.10.50 | | BC CDA Organizer | 2017‑04‑02 20:15:06 |
2.16.840.1.113883.3.1937.777.17.10.52 | Containment | BC Non-Provider Participant | 2017‑04‑02 21:47:46 |
2.16.840.1.113883.3.1937.777.21.10.6 | | CDA Observation | 2018‑07‑30 14:20:18 |
2.16.840.1.113883.3.1937.777.22.10.1 | | CDA ClinicalDocument | 2018‑08‑31 08:59:16 |
2.16.840.1.113883.3.1937.777.24.10.22 | | Omics | 2019‑02‑01 16:40:46 |
2.16.840.1.113883.3.1937.777.24.10.39 | Containment | CDA Author (Body) | 2019‑03‑12 16:40:53 |
2.16.840.1.113883.3.1937.777.24.10.51 | | CDA Procedure B | 2019‑04‑01 15:54:18 |
2.16.840.1.113883.3.1937.777.26.10.1 | | Konsilanfrage | 2018‑07‑20 11:22:22 |
2.16.840.1.113883.3.1937.777.26.10.16 | | Nephrologische Konsilanfrage | 2018‑08‑02 12:52:50 |
2.16.840.1.113883.3.1937.777.29.10.1 | | CDA ClinicalDocument (with StructuredBody) | 2019‑05‑02 16:51:55 |
2.16.840.1.113883.3.1937.777.29.10.2 | Containment | CDA AssignedEntity | 2019‑05‑02 16:57:26 |
2.16.840.1.113883.3.1937.777.29.10.5 | | CDA authenticator | 2019‑05‑02 17:01:51 |
2.16.840.1.113883.3.1937.777.29.10.6 | Containment | CDA recordTarget | 2019‑05‑02 17:05:31 |
2.16.840.1.113883.3.1937.777.29.10.8 | | CDA componentOf | 2019‑05‑03 10:54:09 |
2.16.840.1.113883.3.1937.777.35.10.8 | Containment | AssignedMedicalPractitioner | 2019‑05‑20 17:04:53 |
2.16.840.1.113883.3.1937.777.35.10.9 | | Elektronischer Impfpass ActVaccination (draft) | 2019‑05‑20 17:08:53 |
2.16.840.1.113883.3.1937.777.35.10.11 | | Elektronischer Impfpass CDA Performer (Body) | 2019‑05‑20 17:09:35 |
2.16.840.1.113883.3.1937.777.35.10.12 | | Performer Body (ElektronischerImpfpass) (0) | 2019‑05‑20 17:09:39 |
2.16.840.1.113883.3.1937.777.35.10.13 | Containment | AssignedEntity | 2019‑05‑20 17:26:44 |
2.16.840.1.113883.3.1937.777.35.10.16 | Containment | Elektronischer Impfpass CDA AssignedEntity | 2019‑05‑20 17:51:51 |
2.16.840.1.113883.3.1937.777.35.10.17 | Containment | Elektronischer Impfpass CDA AssignedEntity | 2019‑05‑20 17:51:53 |
2.16.840.1.113883.3.1937.777.35.10.18 | Containment | AssignedNormalPersonEntity | 2019‑05‑20 17:58:32 |
2.16.840.1.113883.3.1937.777.35.10.65 | | Rejected Vaccination (0) | 2019‑05‑24 21:00:39 |
2.16.840.1.113883.3.1937.777.35.10.106 | Containment | CDA Author (body) | 2019‑05‑28 16:12:57 |
2.16.840.1.113883.3.1937.777.60.10.1 | | DK Resume Document Template (1.0) | 2021‑08‑09 13:04:11 |
2.16.840.1.113883.3.1937.777.60.10.3 | | DK Resume Section | 2021‑08‑09 13:15:46 |
2.16.840.1.113883.3.1937.777.60.10.4 | | CDA ClinicalDocument | 2021‑08‑09 13:22:04 |
2.16.840.1.113883.3.1937.777.78.10.8 | | CDA Observation | 2024‑01‑26 11:33:16 |
2.16.840.1.113883.10.12.1 | | CDA ClinicalDocument | 2005‑09‑07 |
2.16.840.1.113883.10.12.2 | | CDA ClinicalDocument (with StructuredBody) | 2005‑09‑07 |
2.16.840.1.113883.10.12.3 | | CDA ClinicalDocument (with nonXMLBody) | 2005‑09‑07 |
2.16.840.1.113883.10.12.101 | Containment | CDA recordTarget | 2005‑09‑07 |
2.16.840.1.113883.10.12.102 | Containment | CDA author | 2005‑09‑07 |
2.16.840.1.113883.10.12.103 | | CDA dataEnterer | 2005‑09‑07 |
2.16.840.1.113883.10.12.105 | Containment | CDA informationRecipient | 2005‑09‑07 |
2.16.840.1.113883.10.12.106 | | CDA legalAuthenticator | 2005‑09‑07 |
2.16.840.1.113883.10.12.107 | | CDA authenticator | 2005‑09‑07 |
2.16.840.1.113883.10.12.108 | Containment | CDA participant | 2005‑09‑07 |
2.16.840.1.113883.10.12.110 | | CDA documentationOf | 2005‑09‑07 |
2.16.840.1.113883.10.12.112 | | CDA component | 2005‑09‑07 |
2.16.840.1.113883.10.12.113 | | CDA componentOf | 2005‑09‑07 |
2.16.840.1.113883.10.12.153 | Containment | CDA AssignedEntity | 2005‑09‑07 |
2.16.840.1.113883.10.12.154 | | CDA Informant | 2005‑09‑07 |
2.16.840.1.113883.10.12.201 | | CDA Section | 2005‑09‑07 |
2.16.840.1.113883.10.12.202 | | CDA StructuredBody | 2005‑09‑07 |
2.16.840.1.113883.10.12.300 | | CDA Clinical Statement | 2005‑09‑07 |
2.16.840.1.113883.10.12.301 | | CDA Act | 2005‑09‑07 |
2.16.840.1.113883.10.12.302 | | CDA Encounter | 2005‑09‑07 |
2.16.840.1.113883.10.12.303 | | CDA Observation | 2005‑09‑07 |
2.16.840.1.113883.10.12.304 | | CDA ObservationMedia | 2005‑09‑07 |
2.16.840.1.113883.10.12.305 | | CDA Organizer | 2005‑09‑07 |
2.16.840.1.113883.10.12.306 | | CDA Procedure | 2005‑09‑07 |
2.16.840.1.113883.10.12.307 | | CDA RegionOfInterest | 2005‑09‑07 |
2.16.840.1.113883.10.12.308 | | CDA SubstanceAdministration | 2005‑09‑07 |
2.16.840.1.113883.10.12.309 | | CDA Supply | 2005‑09‑07 |
2.16.840.1.113883.10.12.314 | Containment | CDA AuthoringDevice | 2005‑09‑07 |
2.16.840.1.113883.10.12.316 | Containment | CDA RelatedEntity | 2005‑09‑07 |
2.16.840.1.113883.10.12.318 | Containment | CDA Author (Body) | 2005‑09‑07 |
2.16.840.1.113883.10.12.319 | | CDA Informant (Body) | 2005‑09‑07 |
2.16.840.1.113883.10.12.323 | | CDA Performer (Body) | 2005‑09‑07 |
2.16.840.1.113883.10.20.6.1.1.2 | | BC CDA Informant | 2016‑10‑17 17:59:51 |
2.16.840.1.113883.10.20.20 | | Genetic Testing Report | 2013‑02‑01 |
2.16.840.1.113883.10.20.22.2.99 | | BC CDA DS componentOf | 2019‑04‑05 03:16:12 |
2.16.840.1.113883.10.21.4.1 | | UV Medication Order (STU1) | 2015‑10‑07 |
2.16.840.1.113883.10.21.4.1 | | UV Medication Order (R1-STU2-ballot) | 2021‑08‑04 17:03:38 |
2.16.840.1.113883.10.21.4.1 | | UV Medication Order (2023) | 2023‑01‑30 08:30:30 |
2.16.840.1.113883.10.21.4.1 | | UV Medication Order (2023) | 2023‑01‑31 10:52:39 |
2.16.840.1.113883.10.21.4.1 | | UV Medication Order (2023) | 2023‑01‑31 11:29:28 |
2.16.840.1.113883.10.21.4.2 | | UV Dispense Request (R1-STU2-ballot) | 2016‑05‑01 |
2.16.840.1.113883.10.21.4.3 | | UV ClinicalStatement Observation (R1-STU2-ballot) | 2016‑05‑01 |
2.16.840.1.113883.10.21.4.7 | | UV Medication Statement (STU1) | 2017‑05‑01 |
2.16.840.1.113883.10.21.4.7 | | UV Medication Statement (R1-STU2-ballot) | 2021‑08‑04 14:09:15 |
2.16.840.1.113883.10.21.4.7 | | UV Medication Statement (2023) | 2023‑01‑30 08:32:34 |
2.16.840.1.113883.10.21.4.8 | | UV Medication Order Reference (R1-STU2-ballot) | 2017‑03‑30 |
2.16.840.1.113883.10.21.4.12 | | UV Comment Activity (R1-STU2-ballot) | 2018‑03‑21 |
2.16.840.1.113883.10.21.4.13 | | UV Medication Administration (R1-STU2-ballot) | 2019‑02‑17 |
2.16.840.1.113883.10.21.4.13 | | UV Medication Administration (2023) | 2023‑01‑30 08:31:37 |
2.16.840.1.113883.10.21.4.15 | | UV Medication Dispense (STU1) | 2019‑02‑17 |
2.16.840.1.113883.10.21.4.15 | | UV Medication Dispense (R1-STU2-ballot) | 2021‑08‑04 16:35:09 |
2.16.840.1.113883.10.21.4.15 | | UV Medication Dispense (2023) | 2023‑01‑30 08:28:25 |
2.16.840.1.113883.10.21.4.15 | | UV Medication Dispense (2023) | 2023‑01‑30 08:33:47 |
2.16.840.1.113883.10.22.3.1 | | IPS Medication Summary Section (STU1) | 2016‑11‑11 |
2.16.840.1.113883.10.22.3.2 | | IPS Allergies and Intolerances Section (STU1) | 2016‑11‑11 |
2.16.840.1.113883.10.22.3.3 | | IPS Problems Section (STU1) | 2017‑02‑15 |
2.16.840.1.113883.10.22.3.4 | | IPS History of Procedures Section (STU1) | 2017‑03‑27 |
2.16.840.1.113883.10.22.3.5 | | IPS Immunizations Section (STU1) | 2017‑04‑05 |
2.16.840.1.113883.10.22.3.6 | | IPS Medical Devices Section (STU1) | 2017‑04‑11 |
2.16.840.1.113883.10.22.3.6 | | IPS Medical Devices Section (2021) | 2021‑10‑20 17:11:42 |
2.16.840.1.113883.10.22.3.7 | | IPS History of Past Illness Section (STU1) | 2017‑04‑12 |
2.16.840.1.113883.10.22.3.8 | | IPS Functional Status Section (STU1) | 2017‑04‑13 |
2.16.840.1.113883.10.22.3.8 | | IPS Functional Status Section (TI-2020) | 2020‑05‑08 19:17:37 |
2.16.840.1.113883.10.22.3.9 | | IPS Plan of Care Section (STU1) | 2017‑04‑13 |
2.16.840.1.113883.10.22.3.9 | | IPS Plan of Care Section (TI-2020) | 2020‑05‑08 18:28:38 |
2.16.840.1.113883.10.22.3.10 | | IPS Social History Section (STU1) | 2017‑04‑13 |
2.16.840.1.113883.10.22.3.10 | | IPS Social History Section (STU1) | 2020‑05‑10 18:52:19 |
2.16.840.1.113883.10.22.3.10 | | IPS Social History Section (TI-2020) | 2020‑05‑10 18:52:32 |
2.16.840.1.113883.10.22.3.11 | | IPS History of Pregnancy Section (STU1) | 2017‑04‑13 |
2.16.840.1.113883.10.22.3.11 | | IPS History of Pregnancy Section (STU1) | 2018‑09‑06 09:46:57 |
2.16.840.1.113883.10.22.3.11 | | IPS History of Pregnancy Section (TI-2020) | 2020‑05‑07 18:46:08 |
2.16.840.1.113883.10.22.3.12 | | IPS Advance Directives Section (STU1) | 2017‑04‑13 |
2.16.840.1.113883.10.22.3.12 | | IPS Advance Directives Section (TI-2020) | 2020‑05‑08 16:38:49 |
2.16.840.1.113883.10.22.3.14 | | IPS Results Section (STU1) | 2017‑04‑30 |
2.16.840.1.113883.10.22.3.16 | | IPS Vital Signs Section (TI-2020) | 2020‑05‑08 19:22:15 |
2.16.840.1.113883.10.22.4.9 | | IPS Result Organizer (STU1) | 2017‑03‑02 |
2.16.840.1.113883.10.22.4.15 | | IPS Immunization (STU1) | 2017‑03‑08 |
2.16.840.1.113883.10.22.4.23 | | IPS ObservationMedia (STU1) | 2017‑04‑06 |
2.16.840.1.113883.10.22.4.23 | | IPS ObservationMedia (2021) | 2021‑09‑02 12:02:16 |
2.16.840.1.113883.10.22.4.39 | | IPS Planned Act (TI-2020) | 2020‑05‑08 18:08:52 |
2.16.840.1.113883.10.22.4.39 | | IPS Planned Act (2022) | 2022‑07‑15 13:55:11 |
2.16.840.1.113883.10.22.4.47 | | IPS Planned Immunization (TI-2020) | 2020‑05‑08 17:29:18 |
2.999.1.1 | | tsc_test1_Obs1 (derived from CDA Observation) | 2016‑07‑01 16:24:10 |
2.999.2.1 | | tsc_test1_Obs2 (derived from tsc_test1_Obs1) | 2016‑07‑01 16:44:35 |